Frontiers in radiology · 2026
Partial splenic embolization as management of portal hypertension-related hypersplenism in pediatric patients.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Salinas-Castro Karen Juliana, Mejia-Quiñones Valentina, Quiceno-Ramirez Santiago, Toro-Gutierrez Juan Sebastian, Botero Verónica, Bustamante-Cristancho Luis Alfonso, Holguín-Holguín Alfonso José
Аннотация
INTRODUCTION: Endovascular partial splenic embolization (PSE) represents a therapeutic alternative for managing portal hypertension and hypersplenism that preserves splenic parenchyma and maintains immune function. This study aimed to describe the therapeutic response and safety profile of PSE in pediatric patients treated over an eleven-year period at a tertiary care center in Colombia.
METHODS: This was a descriptive, retrospective case series. We included 12 pediatric patients aged 8-15 years with hypersplenism secondary to portal hypertension who underwent PSE between 2012 and 2023 at our institution. Hematological parameters, endoscopic findings, and post-procedural complications were analyzed.
RESULTS: The median age was 13 years; nine patients (75%) had portal hypertension and hypersplenism due to portal vein thrombosis, and three (25%) due to hepatic fibrosis. The median percentage of embolized splenic parenchyma was 40% [IQR (25-60)]. Baseline platelet counts were 58,000 × 10⁹/L (50,250-67,000), and baseline leukocyte counts were 3,485 × 10⁹/L (2,728-4,090). Following PSE, statistically significant increases (delta) were observed in platelet count (median 235,000 × 10⁹/L, 95% CI 119,500-450,500; p = 0.0004) and white blood cell count (median 5,600 × 10⁹/L, 95% CI 2,883-8,925; p = 0.002). Eight patients underwent endoscopic follow-up; six demonstrated improvement in esophageal varices grade. Complications included transient abdominal pain and fever. No major adverse events, such as splenic abscess, infarction, rupture or hematoma, were recorded.
CONCLUSIONS: In our series, PSE demonstrated safety and efficacy in managing portal hypertension-related hypersplenism in pediatric patients, with significant improvements in hematological parameters and esophageal varices grade in most cases. PSE represents a valuable minimally invasive alternative to splenectomy, preserving splenic function while achieving therapeutic goals, even in patients requiring repeat interventions.
METHODS: This was a descriptive, retrospective case series. We included 12 pediatric patients aged 8-15 years with hypersplenism secondary to portal hypertension who underwent PSE between 2012 and 2023 at our institution. Hematological parameters, endoscopic findings, and post-procedural complications were analyzed.
RESULTS: The median age was 13 years; nine patients (75%) had portal hypertension and hypersplenism due to portal vein thrombosis, and three (25%) due to hepatic fibrosis. The median percentage of embolized splenic parenchyma was 40% [IQR (25-60)]. Baseline platelet counts were 58,000 × 10⁹/L (50,250-67,000), and baseline leukocyte counts were 3,485 × 10⁹/L (2,728-4,090). Following PSE, statistically significant increases (delta) were observed in platelet count (median 235,000 × 10⁹/L, 95% CI 119,500-450,500; p = 0.0004) and white blood cell count (median 5,600 × 10⁹/L, 95% CI 2,883-8,925; p = 0.002). Eight patients underwent endoscopic follow-up; six demonstrated improvement in esophageal varices grade. Complications included transient abdominal pain and fever. No major adverse events, such as splenic abscess, infarction, rupture or hematoma, were recorded.
CONCLUSIONS: In our series, PSE demonstrated safety and efficacy in managing portal hypertension-related hypersplenism in pediatric patients, with significant improvements in hematological parameters and esophageal varices grade in most cases. PSE represents a valuable minimally invasive alternative to splenectomy, preserving splenic function while achieving therapeutic goals, even in patients requiring repeat interventions.